Scailyte AG, a Swiss startup in the emerging and rapidly growing field of single-cell technologies, raised CHF 2.75M in seed funding and gained Swisscom Ventures as a strategic investor. Zürcher Kantonalbank also joined the financing round, alongside the existing shareholders, thus reaffirming their trust in the competence and vision of Scailyte’s team. Dominique Megret, Head of Swisscom Ventures, […]

Bala Cynwyd, P.A., USA — Effective today, or as contracts allow, Purolite Corporation will increase prices for ion exchange resins, adsorbents, chelants, catalysts and select specialty resins to an average of 10%. Price adjustments are necessary due to higher raw material prices, as well as increased costs for environmental, health and safety regulations. The increase […]

MONTRÉAL–AmorChem II is proud to announce the closing of its first financing of a university project. The venture capital fund has reached an agreement with Univalor, Dr Éric Lécuyer of the Montreal Clinical Research Institute (“IRCM”), Dr. Mathieu Blanchette and Dr. Jérôme Waldispühl of McGill University to collaborate on a project focusing on short sequences […]

TORONTO, ON – FACIT, a business accelerator for Ontario oncology innovations, announced a follow-on investment in Toronto-based start-up DNAstack. The start-up is developing advanced data standards and technologies that make it easier for scientists to find, access, analyze and share complex and large volumes of multi-omics data in the cloud. In conjunction with this investment, FACIT […]

– Unique Cell-Free Bioproduction Platform delivers cost effective, high quality RNA solutions to human, animal and crop challenges. – Round will fund the expansion of discovery, development and commercial capabilities. – An expanded plant sciences team will drive the advancement of a bio-performance portfolio. MEDFORD, Mass. — GreenLight™ Biosciences, Inc., the bio-performance company developing RNA-based solutions for agriculture […]

   ANN ARBOR, MI Investment Drives Commercial Expansion into Pharma and Clinical Diagnostic Labs  Genomenon® announced that it has completed a $2.5M equity financing round. The financing will expand the company’s commercial reach with clinical diagnostic labs, biotech, and pharmaceutical companies. Genomenon connects patient DNA with the evidence in scientific literature to help doctors provide faster […]

— FY18 Product and Service Revenue of $83.5 million, Exceeding High-End of Guidance — — Generated Pre-Orders for More Than 30 GeoMx™ Digital Spatial Profilers — SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided preliminary operational and financial results for the fourth quarter and fiscal […]

Investment in R&D will extend capabilities of computational platform and support growth of partnered and proprietary programs NEW YORK – Schrödinger, a privately held company revolutionizing drug discovery through advanced molecular simulations, today announced the closing of an $85 million financing to support continued growth and innovation of its computational platform and expansion of its […]

San Francisco, Jan. 4, 2019: SOPHiA GENETICS, a leading health tech company, announced today the closing of a $77 million investment round to accelerate the democratization of Data- Driven Medicine. The round was led by Generation Investment Management, a pioneer of sustainable investing, with offices in London and San Francisco. Generation were joined by Idinvest Partners, […]

SOUTH SAN FRANCISCO, Calif.–Verily, an Alphabet company, today announced a $1 billion investment round, led by Silver Lake, as it advances plans on business strategies that are additive and complementary to its current life sciences portfolio. Other new investors in the round include Ontario Teachers’ Pension Plan and other global investment management firms. The capital […]